Metastatic Malignant Neoplasm in the Brain clinical trials
Showing 51–71 of 71 active trials. Describe your situation to see which ones you may be eligible for.
- Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
- MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
- Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
- MeDex: No Perioperative Dexamethasone in Brain Metastases
- Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
- Multi-disciplinary Care for Brain Metastases
- Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
- IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases
- Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
- Sac-TMT for Active TNBC Brain Metastases
- MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
- Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
- Evaluation of Ascorbate-Meglumine Therapeutic for SRS
- Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
- Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
- Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.